# An Open-label Clinical Trial to Compare the Safety and Effectiveness of Adaptive Versus Conventional Deep Brain Stimulation

> **NCT05262348** · NA · WITHDRAWN · sponsor: **Newronika**

## Conditions studied

- Parkinson Disease

## Interventions

- **DEVICE:** adaptive DBS delivered through AlphaDBS IPG System
- **DEVICE:** conventional DBS delivered through AlphaDBS IPG System

## Key facts

- **NCT ID:** NCT05262348
- **Lead sponsor:** Newronika
- **Sponsor class:** INDUSTRY
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** WITHDRAWN
- **Start date:** 2022-08
- **Primary completion:** 2024-08-30
- **Final completion:** 2026-12-31
- **Target enrollment:** 0 (ACTUAL)
- **Why stopped:** The study design has been revised and this protocol was never activated.
- **Last updated:** 2024-08-12


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05262348

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05262348, "An Open-label Clinical Trial to Compare the Safety and Effectiveness of Adaptive Versus Conventional Deep Brain Stimulation". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT05262348. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*